Please login to the form below

Not currently logged in
Email:
Password:

drospirenone

This page shows the latest drospirenone news and features for those working in and with pharma, biotech and healthcare.

Bayer expands birth control business with $1.1bn Conceptus acquisition

Bayer expands birth control business with $1.1bn Conceptus acquisition

levonorgestrel) and the Yaz (drospirenone/ethinyl estradiol) family of oral contraceptives.

Latest news

  • EMA starts contraceptive safety probe EMA starts contraceptive safety probe

    France's move was prompted by reports of blood clots (venous thromboembolism) with the more recently-introduced oral contraceptive products, which incorporate newer progestins such as drospirenone, gestodene and desogestrel, rather ... Leading third- and

  • Bayer gets EU backing for Flexyess contraceptive Bayer gets EU backing for Flexyess contraceptive

    Flexyess (drospirenone/ethinylestradiol) - which is also known as Yvidually - has been granted authorisation by the European Commission (EC) under its decentralised approval procedure and is expected to be cleared by national ... US indicating that

  • Bayer raises 2012 forecasts on increasing revenues Bayer raises 2012 forecasts on increasing revenues

    The Yaz/Yasmin/Yasminelle (drospirenone and ethinyl estradiol) contraceptive franchise fell 6.4 per cent to 254m, affected by generic competition and the addition of warnings on labelling in April in

  • Study finds MSD’s NuvaRing riskier than oral contraceptives

    They note this increase in risk is equivalent to that seen with COCs using third- and fourth-generation progestins, notably desogestrel, gestodene and drospirenone, which have had warnings added to their

  • Bayer to pay minimum of $110m to settle birth control lawsuits

    Bloomberg's sources have requested to remain anonymous. Bayer had been accused of misleading the public about the health risks of its products, with safety reviews suggesting that drospirenone-containing birth ... This led to the US Food and Drug

More from news
Approximately 1 fully matching, plus 16 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics